Liang Qifeng,Wen Zhe,Liang Jiankun,et al.The surgical treatment of congenital hyperinsulinism[J].Journal of Clinical Pediatric Surgery,2021,20(07):612-618.[doi:10.12260/lcxewkzz.2021.07.003]
先天性高胰岛素血症手术治疗效果分析
- Title:
- The surgical treatment of congenital hyperinsulinism
- 关键词:
- 先天性高胰岛素血症/外科学; 治疗结果
- Keywords:
- Congenital Hyperinsulinism/SU; Treatment Outcome
- 分类号:
- R725.76;R726.12
- 摘要:
- 目的 分析手术治疗先天性高胰岛素血症（congenital hyperinsulinism，CHI）的有效性及安全性。方法 2012年12月至2017年12月在广州市妇女儿童医疗中心行胰腺部分或次全切除术治疗的9例CHI患者，其中男6例，女3例，术前均行B超、CT和MR检查，予二氮嗪治疗7~10 d无效后行手术治疗，手术时日龄为32~163 d，术后进行随访观察。结果 1例术前行18F-DOPA PET-CT检查，考虑为局灶型CHI，但术中冰冻病理证实为非典型型CHI；术后石蜡病理证实局灶型CHI 1例，弥漫型CHI 7例，非典型型CHI 1例。1例非典型型CHI行胰头次全切除术和胰体尾-空肠吻合术，术后只需三餐外定期口服果汁即可维持血糖于正常水平。1例局灶型CHI患者行95%胰腺次全切除后，出院时血糖波动于4.2~7.2 mmol/L之间，不需药物治疗，该患者随访至今，正常饮食情况下均可维持正常血糖。7例弥漫型CHI患者均行胰腺次全切除术，其中1例行90%胰腺切除的患者出院时仍有间断性低血糖，需口服二氮嗪才能控制，术后第2年发展为Ⅰ型糖尿病，目前需要口服药物降低血糖；1例行95%胰腺切除的患者出院后，在饮奶前或夜间偶有低血糖，添加糖水喂养方可控制，术后第3年发展为Ⅰ型糖尿病，目前需要用胰岛素泵降低血糖；其余5例均行95%胰腺切除，出院时无低血糖发作，血糖波动于3.9~10 mmol/L之间，无需药物治疗。目前5例均正常饮食，血糖正常，无低血糖或糖尿病发生。结论 对二氮嗪等药物治疗无效的CHI患者需要采用手术治疗。18F-DOPA PET-CT对非典型型CHI的诊断价值需要进一步探讨。弥漫型CHI患者行胰腺次全切术可有效控制血糖，部分患者可获得正常血糖，但部分患者会发展为Ⅰ型糖尿病，尤其是术后短期仍出现低血糖发作的患者，发生糖尿病的可能性更大。对大多数弥漫型CHI患者行95%胰腺次全切是合适的。术前PET-CT对鉴别局灶型CHI有重要意义，术前PET-CT和术中冰冻病理检查有助于明确CHI的分型，指导选择正确的手术方式。
- Abstract:
- Objective The purpose of the study is to discuss the strategy,effectiveness and safety of surgical treatment for CHI patients by using the clinical data in our hospital retrospectively.Methods From December 2012 to December 2017,a total of 9 patients with CHI underwent partial or subtotal pancreatectomy in Guangzhou Women and Chilren’s Medical Center,including 6 males and 3 females.Preoperative ultrasonography,CT and MR examinations were performed on all of them,and the age of operation ranged from 32 days to 163 days.Results 1 patient was considered as focal CHI by preoperative 18F-DOPA PET-CT examination,but was confirmed as atypical CHI by intraoperative frozen pathology.1 case of focal CHI,7 cases of diffuse CHI and 1 case of atypical CHI were confirmed by postoperative paraffin pathology.After partial pancreatectomy for atypical type,the patient only needs regular intake of juice and starch to maintain normal blood glucose except for three meals now.The patient with focal CHI underwent 95% subtotal pancreatectomy,and he needed no drugs at discharge with his blood glucose fluctuating between 4.2 and 7.2mmol/L.At present,the patient has a normal diet and maintains normal blood glucose.All 7 diffuse CHI patients underwent subtotal pancreatectomy.1 patient who underwent 90% pancreas resection still had intermittent hypoglycemia at discharge and needed oral diazoxide to control her blood glucose.She developed type 1 diabetes 2 years after surgery and needs oral drugs to lower her blood glucose now.At discharge,1 patient who underwent 95% pancreas resection had occasional hypoglycemia before milk drinking or at night,requiring additional sugar water feedings to control her blood glucose.She developed type 1 diabetes in the third postoperative year and needs an insulin pump to lower blood glucose until now.The remaining 5 patients underwent 95% pancreatectomy and were fed normally at discharge without episodes of hypoglycemia.Their blood glucose fluctuated between 3.9 and 10mmol/L without drug treatment.At present,all the 5 patients have normal diet and no hypoglycemic episode or diabetes.Conclusion In our study,patients with CHI who have failed to respond to medication such as diazoxide may be treated surgically.The diagnostic value of 18F-DOPA PET-CT in atypical CHI needs to be further explored.Patients with diffuse CHI can effectively control blood glucose by subtotal pancreatectomy,and some of them can obtain normal blood glucose,but some of them will develop into type 1 diabetes,especially those who still have hypoglycemic episodes in the short term after the surgery have a higher possibility of developing diabetes.A 95% subtotal pancreatectomy is appropriate for most patients with diffuse CHI.Preoperative PET-CT is of great significance for identifying focal CHI.Preoperative PET-CT and intraoperative frozen pathology examination can confirm the classification of CHI and guide the surgical procedure.
参考文献/References:
1 Shah P,Demirbilek h,Hussain k.Persistent hyperinsulinaemic hypoglycaemia in infancy[J].Semin Pediatr Surg,2014,23(2):76-82.DOI:10.1053/j.sempedsurg.2014.03.005.
2 Arnoux JB,Verkarre V,Saint-Martin C.Congenital hyperinsulinism:current trends in diagnosis and therapy[J].Orphanet J Rare Dis,2011,6:63-77.DOI:10.1186/1750-1172-6-63.
3 Yorifuji T,Horikawa R,Hasegawa T,et al.Clinical practice guidelines for congenital hyperinsulinism[J].Clin Pediatr Endocrinol,2017,26(3):127-152.DOI:10.1297/cpe.26.127.
4 Lovvorn HN 3rd,Nance ML,Ferry RJ Jr,et al.Congenital hyperinsulinism and the surgeon lessons learned over 35 years[J].J Pediatr Surg,1999,34(5):786-793.DOI:10.1016/s0022-3468(99)90374-3.
5 Scott Adzick N.Surgical treatment of congenital hyperinsulinism[J].Semin Pediatr Surg,2020,29(3):150924.DOI:10.1016/j.sempedsurg.2020.150924.
6 Laimon W,Aboelenin HM,El Tantawi NT.Clinical characteristics,outcome,and predictors of neurological sequelae of persistent congenital hyperinsulinism:A single tertiary center experience[J].Pediatr Diabetes,2021,22(3):388-399.DOI:10.1111/pedi.13186.
7 Kapoor RR,Flanagan SE,Arya VB,et al.Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism[J].Eur J Endocrinol,2013,168(4):557-564.DOI:10.1530/EJE-12-0673.
8 Snider KE,Becker S,Boyajian L,et al.Genotype and phenotype correlations in 417 CHIldren with congenital hyperinsulinism[J].J Clin Endocrinol Metab,2013,98(2):E355-E363.DOI:10.1210/jc.2012-2169.
9 Flanagan SE,Kapoor RR,Hussain K.Genetics of congenital hyperinsulinemic hypoglycemia[J].Semin Pediatr Surg,2011,20(1):13-17.DOI:10.1053/j.sempedsurg.2010.10.004.
10 Verkarre V,Fournet JC,de Lonlay P,et al.Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia[J].J Clin Invest,1998,102(7):1286-1291.DOI:10.1172/JCI4495.
11 Suchi M,MacMullen CM,Thornton PS,et al.Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism[J].Mod Pathol,2006,19(1):122-129.DOI:10.1038/modpathol.3800497.
12 Rahier J,Guiot Y,Sempoux C.Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism[J].Semin Pediatr Surg,2011,20(1):3-12.DOI:10.1053/j.sempedsurg.2010.10.010.
13 Adzick NS,De Leon DD,States LJ,et al.Surgical treatment of congenital hyperinsulinism:Results from 500 pancreatectomies in neonates and CHIldren[J].J Pediatr Surg,2019,54(1):27-32.DOI:10.1016/j.jpedsurg.2018.10.030.
14 Laje P,Palladino AA,Bhatti TR,et al.Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism[J].J Pediatr Surg,2013,48(12):2511-2516.DOI:10.1016/j.jpedsurg.2013.05.016.
15 Kalish JM,Boodhansingh KE,Bhatti TR,et al.Congenital hyperinsulinism in CHIldren with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome[J].J Med Genet,2016,53(1):53-61.DOI:10.1136/jmedgenet-2015-103394.
16 Arya VB,Guemes M,Nessa A,et al.Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations[J].Eur J Endocrinol,2014,171(6):685-695.DOI:10.1530/EJE-14-0353.
17 Zhang W,Liu L,Wen Z,et al.A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form:Not a focal lesion in the pancreas reported by (1)(8) F-DOPA-PET/CT scan[J].Gene,2015,572(2):222-226.DOI:10.1016/j.gene.2015.07.012.
18 Lord K,Dzata E,Snider KE,et al.Clinical presentation and management of CHIldren with diffuse and focal hyperinsulinism:a review of 223 cases[J].J Clin Endocrinol Metab,2013,98(11):E1786-E1789.DOI:10.1210/jc.2013-2094.
19 Brunelle F,Negre V,Barth MO,et al.Pancreatic venous samplings in infants and CHIldren with primary hyperinsulinism[J].Pediatr Radiol,1989,19(2):100-103.DOI:10.1007/bf02387895.
20 Ferry RJ Jr,Kelly A,Grimberg A,et al.Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism[J].J Pediatr,2000,137(2):239-246.DOI:10.1067/mpd.2000.107386.
21 任静芸,杨吉刚.18F-L-DOPA PET/CT显像诊断先天性高胰岛素血症的研究进展[J].国际放射医学核医学杂志,2015,39(1):67-70.DOI:10.3760/cma.j.issn.1673-4114.2015.01.014. Ren JY,Yang JG.Research progress of 18F-L-DOPA PET/CT in the diagnosis of congenital hyperinsulinism[J].J Radiat Med Nucl Med,2015,39(1):67-70.DOI:10.3760/cma.j.issn.1673-4114.2015.01.014.
22 Laje P,States LJ,Zhuang H,et al.Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism[J].J Pediatr Surg,2013,48(2):388-393.DOI:10.1016/j.jpedsurg.2012.11.025.
23 Christiansen CD,Petersen H,Nielsen AL,et al.18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism:a blinded evaluation[J].Eur J Nucl Med Mol Imaging,2018,45(2):250-261.DOI:10.1007/s00259-017-3867-1.
24 王乐,沈丽萍.运用达芬奇手术机器人辅助系统治疗小儿胰腺肿瘤[J].临床小儿外科杂志,2018,17(5):363-366.DOI:10.3969/j.issn.1671-6353.2018.05.011. Wang L,Shen LP.Treatment of pediatric pancreatic tumors by robotic surgical system[J].J Clin Ped Sur,2018,17(5):363-366.DOI:10.3969/j.issn.1671-6353.2018.05.011.
25 Pierro A,Nah SA.Surgical management of congenital hyperinsulinism of infancy[J].Semin Pediatr Surg,2011,20(1):50-53.DOI:10.1053/j.sempedsurg.2010.10.009.
26 Beltrand J,Caquard M,Arnoux JB,et al.Glucose metabolism in 105 CHIldren and adolescents after pancreatectomy for congenital hyperinsulinism[J].Diabetes Care,2012,35(2):198-203.DOI:10.2337/dc11-1296.
27 Lord K,Radcliffe J,Gallagher PR,et al.High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism[J].J Clin Endocrinol Metab,2015,100(11):4133-4139.DOI:10.1210/jc.2015-2539.
28 Arya VB,Senniappan S,Demirbilek H,et al.Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism[J].PLoS One,2014,9(5):e98054.DOI:10.1371/journal.pone.0098054.
相似文献/References:
[1]何联杨星海陈海涛.156例小儿精索静脉曲张的临床分析[J].临床小儿外科杂志,2011,10(01):0.
[2]汪兵 苗武胜 张亮 吴永涛 张博浩.克氏针张力带固定治疗儿童陈旧性肱骨外髁骨折的疗效观察[J].临床小儿外科杂志,2011,10(03):176.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):176.
[3]刁美 林海伟 明安晓 李龙 郑伟. 腹腔镜与开放性肝管空肠吻合术治疗先天性[J].临床小儿外科杂志,2011,10(05):325.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):325.
[4]周维 李娟 黄国显 陈海琛 胡杨 徐延波. Snodgrass及Mathieu术式治疗前型尿道下裂的对比分析[J].临床小儿外科杂志,2011,10(05):364.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):364.
[5]段光琦 毕允力 张敏 管肖浩. Koyanagi手术和改良手术治疗重型尿道下裂[J].临床小儿外科杂志,2011,10(05):389.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):389.
[6]蒋璐杏 刘少红 陈朝辉 李绿容. 造口护肤粉与皮肤保护膜联合应用于小儿肠造瘘周围皮炎的疗效观察[J].临床小儿外科杂志,2011,10(05):398.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):398.
[7]杜真 张溪英 朱诗利 王江平 刘晶晶 邝日裕. 复方利多卡因乳膏在小儿全麻气管插管中的应用[J].临床小儿外科杂志,2011,10(06):461.
[J].Journal of Clinical Pediatric Surgery,2011,10(07):461.
[8]张金山 李龙 侯文英 刘树立 刁美 李胜利 明安晓 刘垚 王海滨. 影响胆总管囊肿手术疗效的因素分析[J].临床小儿外科杂志,2012,11(01):7.
[9]贾炜 余家康 钟微 李瑞琼 何秋明 夏慧敏. 先天性食管闭锁12年疗效评价[J].临床小儿外科杂志,2012,11(01):20.
[10]彭荣 杨星海 张伊 凡丁锋 黄姗. 先天性肠闭锁352例诊治体会[J].临床小儿外科杂志,2012,11(01):45.
备注/Memo
收稿日期:2021-04-24。
基金项目:广州市科技局基础与应用基础研究项目（编号：202002030465）
通讯作者:温哲,Email:wenzhe2005@163.con